Last updated on June 2019

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

Brief description of study

This is a randomized, double-blind, placebo-controlled, crossover, dose escalation study of bradanicline in subjects with chronic cough

Detailed Study Description

This study will have two 21-day treatment periods separated by a 14-day washout period. There will be a 14-day follow-up period.

Clinical Study Identifier: NCT03622216

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.